⌘K

Home/Filings/4/A/0001493152-23-036424

4/A//SEC Filing

Bernards Rene 4/A

Accession 0001493152-23-036424

CIK 0001335105other

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 8:39 PM ET

Size

6.5 KB

Accession

0001493152-23-036424

Insider Transaction Report

Form 4/AAmended

Period: 2023-10-02

LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT

Director

Transactions

Purchase
Common Stock
2023-10-03$2.51/sh+5,527$13,873→ 25,000 total
Purchase
Common Stock
2023-10-02$2.29/sh+4,473$10,243→ 19,473 total

Footnotes (2)

[F1]The Reporting Person acquired an aggregate of 4,473 shares in numerous trades at prices ranging from $2.29-$2.40
[F2]The Reporting Person acquired an aggregate of 5,527 shares in numerous trades ranging from $2.51-$2.58

Documents

1 file

4
ownership.xml

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

Entity typeother

Related Parties

1

filerCIK 0001939159

Filing Metadata

Form type: 4/A
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 8:39 PM ET
Size: 6.5 KB

View on SEC.gov